Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion

A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor in at least one pharmaceutically acceptable water-soluble polymer and at least on...

Full description

Saved in:
Bibliographic Details
Main Authors ALANI, Laman, Rosenberg, Joerg, Ghosh, Soumojeet, Reinhold, Ulrich, Berndl, Gunther, Liepold, Bernd, Breitenbach, Joerg
Format Patent
LanguageEnglish
Hungarian
Published 28.07.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor in at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant.
Bibliography:Application Number: HUE10181264